Silvia Sabatini

Pisa, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Metabolomic profile differs between LADA and type 1 diabetes identifying tryptophan metabolism as a pathway involved in the heterogeneity of autoimmune diabetes.

Metabolomic profile differs between LADA and type 1 diabetes identifying tryptophan metabolism as a pathway involved in the heterogeneity of autoimmune diabetes.

Journal: Diabetologia

Published: February 20, 2026

Diet-induced hepatic and mitochondrial lipid remodeling engages one-carbon metabolism under preserved mitochondrial function.

Diet-induced hepatic and mitochondrial lipid remodeling engages one-carbon metabolism under preserved mitochondrial function.

Journal: Free radical biology & medicine

Published: February 12, 2026

Dapagliflozin modulates plasma lipidomic profile and urinary metabolite excretion in type 2 diabetes.

Dapagliflozin modulates plasma lipidomic profile and urinary metabolite excretion in type 2 diabetes.

Journal: Cardiovascular diabetology

Published: September 13, 2025

Personalizing bariatric metabolic surgery: Predictors of weight-loss success and risk of weight recurrence.

Personalizing bariatric metabolic surgery: Predictors of weight-loss success and risk of weight recurrence.

Journal: Metabolism: clinical and experimental

Published: June 19, 2025

Metabolic effects and mechanism of action of the pan-PPAR agonist lanifibranor.

Metabolic effects and mechanism of action of the pan-PPAR agonist lanifibranor.

Journal: Journal of hepatology

Published: February 26, 2025

Lipid metabolism in MASLD and MASH: From mechanism to the clinic.

Lipid metabolism in MASLD and MASH: From mechanism to the clinic.

Journal: JHEP reports : innovation in hepatology

Published: April 23, 2024

Hepatic glucose metabolism in the steatotic liver.

Hepatic glucose metabolism in the steatotic liver.

Journal: Nature reviews. Gastroenterology & hepatology

Published: December 13, 2023

GLP-1 Receptor Agonist Treatment Improves Fasting and Postprandial Lipidomic Profiles Independently of Diabetes and Weight Loss.

GLP-1 Receptor Agonist Treatment Improves Fasting and Postprandial Lipidomic Profiles Independently of Diabetes and Weight Loss.

Journal: Diabetes

Published: December 08, 2023

Baseline phenotypes with preserved β-cell function and high insulin concentrations have the best improvements in glucose tolerance after weight loss: results from the prospective DEXLIFE and EGIR-RISC studies.

Baseline phenotypes with preserved β-cell function and high insulin concentrations have the best improvements in glucose tolerance after weight loss: results from the prospective DEXLIFE and EGIR-RISC studies.

Journal: Metabolism: clinical and experimental

Published: November 27, 2023

Hepatic glucose production rises with the histological severity of metabolic dysfunction-associated steatohepatitis.

Hepatic glucose production rises with the histological severity of metabolic dysfunction-associated steatohepatitis.

Journal: Cell reports. Medicine

Published: August 25, 2023

Fatty Liver Index (FLI) Identifies Not Only Individuals with Liver Steatosis but Also at High Cardiometabolic Risk.

Fatty Liver Index (FLI) Identifies Not Only Individuals with Liver Steatosis but Also at High Cardiometabolic Risk.

Journal: International journal of molecular sciences

Published: August 13, 2023

Altered fatty acid metabolism rewires cholangiocarcinoma stemness features.

Altered fatty acid metabolism rewires cholangiocarcinoma stemness features.

Journal: JHEP reports : innovation in hepatology

Published: August 05, 2023

Showing 1-12 of 28

Last Updated: 09/26/2026